AccessibilityHelpAbout Us
Numinus Wellness logo

Numinus Wellness(OTC) NUMIF

Market Cap$6.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-97%
5 Year-97%
1 Year-38%
1 Month-43%
$0.02
+11.91%
+0.00Today
Numinus Wellness last closing stock price
MetricPriceDate
Last closeUSD 0.022026-09-16
Numinus Wellness stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-18.92%USD 0.032026-09-09
1 month-43.09%USD 0.042026-08-17
3 month+5%USD 0.022026-06-18
Year to date-30%USD 0.032025-12-31
1 year-38.24%USD 0.032025-09-16
3 year-87.71%USD 0.172023-09-15
5 year-96.55%USD 0.612021-09-17
Since inception-97.1%USD 0.722020-05-20

Numinus Wellness Financials at a Glance

Market Cap

$6.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$6.87M

Net Income (TTM)

CA$7.00M

EPS (TTM)

$0.02

P/E Ratio

1.33

Dividend

$0.00

Beta (Volatility)

1.08 (Average)

Price

$0.02

Volume

3,413

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.01 - $0.06

Estimated Earnings Date

Oct 28, 2026

NUMIF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Numinus Wellness

Numinus Wellness Inc. is dedicated to pioneering and delivering psychedelic-assisted psychotherapy, aiming to reshape the mental healthcare landscape. The company operates through two primary divisions: Salvation Botanicals and Numinus Health, focusing on innovative therapeutic solutions and comprehensive laboratory services.

Products and Services
  • Salvation Botanicals offers laboratory services for psychedelics and cannabis products
  • Numinus Health provides psychotherapy, counselling, and neurofeedback therapies
  • Training and operational resources for practitioners in mental health and substance abuse
Growth Outlook
  • Increasing demand for mental health solutions drives market potential
  • Expansion of psychedelic therapy research supports innovative treatment options
  • Strategic partnerships enhance service offerings and market reach
Financial Highlights
  • Recent quarterly revenue of CAD 1,802,942 shows growth from previous quarters
  • Gross profit margin improved to 48.26% in the latest quarter
  • Cash and cash equivalents increased to CAD 822,835, indicating liquidity
Numinus Wellness Inc. is positioned at the forefront of a rapidly evolving sector, focusing on mental health solutions through innovative therapies. The company's dual approach, combining laboratory services with therapeutic practices, allows for a comprehensive offering that addresses the growing need for effective mental health care. Recent financial performance indicates a positive trajectory, with increasing revenue and improved gross profit margins. The strategic focus on partnerships and research further enhances the potential for growth in this emerging market. As the demand for mental health solutions continues to rise, Numinus Wellness Inc. stands to play a significant role in shaping the future of mental healthcare.
AI Generated • Aug 22, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

35

CEO

Michael Tan, MBA

Website

numinus.com

Headquarters

Vancouver, BC V6B 3M1, CA

NUMIF Financials

Key Financial Metrics (TTM)

Gross Margin

27.97%

Operating Margin

-280.87%

Net Income Margin

-471.23%

Return on Equity

-265.91%

Return on Capital

N/A

Return on Assets

-182.35%

Earnings Yield

75.19%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

320.55M

Volume

3.41K

Avg. Volume

142.66K

Financials (TTM)

Gross Profit

CA$3.39M

Operating Income

-CA$1.13M

EBITDA

-CA$757.56K

Operating Cash Flow

CA$1.25M

Capital Expenditure

-CA$26.66K

Free Cash Flow

CA$1.23M

Cash & ST Invst.

CA$448.48K

Total Debt

CA$1.59M

Numinus Wellness Performance Analysis

Numinus Wellness annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-08-31CAD 5,105,143N/A
20232023-08-31CAD 2,786,678-45.4%
20242024-08-31CAD 3,155,89413.2%
20252025-08-31CAD 5,484,57973.8%
Numinus Wellness sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-08-3129.1%
Q12025-11-30-43.8%
Q22026-02-2824.9%
Q32026-05-31-1.7%
Numinus Wellness annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-08-31CAD -0.16N/A
20232023-08-31CAD -0.09-47.7%
20242024-08-31CAD -0.05-42.6%
20252025-08-31CAD -0.01-82.8%
Numinus Wellness sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-08-311139.1%
Q12025-11-30-100.0%
Q22026-02-28N/A
Q32026-05-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

CA$1.60M

-11.0%

Gross Profit

CA$820.76K

-5.7%

Gross Margin

51.15%

N/A

Market Cap

$6.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$33.66K

N/A

Employees

200

N/A

Net Income

-CA$299.51K

+57.9%

EBITDA

-CA$159.32K

+73.5%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

CA$448.48K

-45.5%

Total Debt

CA$1.59M

-31.4%

Accounts Receivable

CA$1.15M

-18.8%

Inventory

CA$0.00

N/A

Long Term Debt

CA$905.81K

-47.8%

Short Term Debt

CA$689.11K

+16.9%

Return on Assets

-1.82%

N/A

Return on Invested Capital

-5.40%

N/A

Free Cash Flow

-CA$196.53K

-150.0%

Operating Cash Flow

-CA$196.53K

-150.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LUFFFHerbal Dispatch Inc.
$0.02+13.30%
FPCGAvem Health Partners, Inc.
$1,025.00+0.00%
PBSVPharma-Bio Serv, Inc.
$0.46+15.97%
ALRTFALR Technologies Inc.
$0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$110.56+9.41%
NOKNokia
$10.49+3.40%
AEMDAethlon Medical
$6.49+353.85%
SPCXSpace Exploration Technologies
$154.97+2.71%

Questions About NUMIF

What is the current price of Numinus Wellness?

Numinus Wellness is trading at $0.02 per share.

What is the 52-week range for Numinus Wellness?

Over the past 52 weeks, Numinus Wellness has traded between $0.01 and $0.06.

How much debt does Numinus Wellness have?

As of the most recent reporting period, Numinus Wellness reported total debt of CA$1.15M.

How much cash does Numinus Wellness have on hand?

Numinus Wellness reported CA$324.71K in cash and cash equivalents in its most recent financial results.

What is Numinus Wellness’s dividend yield?

Numinus Wellness does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services